45 Biggest Movers From Yesterday

Gainers

• Sorrento Therapeutics, Inc. SRNE shares gained 94.4% to close at $3.11 on Monday after the company announced it has recieved and rejected an unsolicited, all cash proposal from two biopharmaceutical companies between $3-$5 per share in cash.
• JanOne Inc. JAN shares climbed 54.1% to close at $3.94 on Monday after the company announced it purchased a worldwide exclusive license for TV1001SR, a treatment for peripheral arterial disease. No terms were disclosed.
• RAPT Therapeutics, Inc. RAPT gained 44.3% to close at $ 29.47 after several firms initiated coverage on the company's stock with bullish ratings.
• The Medicines Company MDCO shares rose 22.3% to close at $83.80 after the company announced it will be acquired by Novartis AG for $85 per share.
• Neoleukin Therapeutics, Inc. NLTX gained 22.2% to close at $4.24.
• Zynex, Inc. ZYXI gained 20.2% to close at $10.72.
• Clovis Oncology, Inc. CLVS rose 18.6% to close at $ 10.27 on above-average volume.
• The Peck Company Holdings, Inc. PECK rose 17.5% to close at $2.69.
• Aquestive Therapeutics, Inc. AQST shares rose 17.3% to close at $7.54 after the company received the FDA approval for EXSERVAN for the treatment of amyotrphic lateral sclerosis.
• Arrowhead Pharmaceuticals Inc ARWR gained 15.8% to close at $56.99 after Baird upgraded the company's stock from Neutral to Outperform and raised the price target from $39 to $70.
• Akebia Therapeutics, Inc. AKBA rose 15.7% to close at $4.87.
• BioCryst Pharmaceuticals, Inc. BCRX climbed 15.1% to close at $2.59.
• GlobalSCAPE, Inc. GSB surged 15.1% to close at $13.07.
• Ruhnn Holding Limited RUHN rose 15% to close at $8.11.
• Enochian Biosciences Inc. ENOB climbed 14.9% to close at $6.74.
• InMode Ltd. INMD gained 14.7% to close at $47.66. This could potentially be a rebound after the stock the dropped approximately 23% over the past 4 trading sessions.
• BioXcel Therapeutics, Inc. BTAI rose 13.6% to close at $6.85.
• Hallador Energy Company HNRG rose 13.6% to close at $2.93.
• Calithera Biosciences, Inc. CALA jumped 13.1% to close at $4.58.
• Ferro Corporation FOE rose 13% to close at $14.36 following reports that the company could be exploring strategic options.
• U.S. Silica Holdings, Inc. SLCA gained 12.8% to close at $5.13.
• Chico's FAS, Inc. CHS climbed 11.5% to close at $4.18.
• Kamada Ltd. KMDA rose 10.7% to close at $7.64.
• ArQule, Inc. ARQL gained 9.7% to close at $8.98. The company earlier announced it will present clinical data from its Phase 1 study of ARQ 531 at the ASH Annual Meeting on December 9th.
• Five Prime Therapeutics, Inc. FPRX climbed 9.6% to close at $3.88.
• Zscaler, Inc. ZS shares rose 8.8% to close at $50.39 after Bank of America upgraded the company's stock from Neutral to Buy.
• Intercept Pharmaceuticals, Inc. ICPT rose 8.4% to close at $96.34. Intercept Pharma disclosed that the FDA has accepted New Drug Application for obeticholic acid for the treatment of fibrosis due to nonalcoholic steatohepatitis and granted priority review.
• IVERIC bio, Inc. ISEE climbed 7.9% to close at $3.56.
• IEC Electronics Corp. IEC shares rose 7.8% to close at $8.41.
• Tiffany & Co. TIF rose 6.2% to close at $133.25 after LVMH confirmed an agreement to buy the company in a $16.2 billion bid.

Losers

• CymaBay Therapeutics Inc CBAY shares tumbled 76.1% to close at $1.33 on Monday after the company reported a halt in the clinical development of its Seladelpar.
• La Jolla Pharmaceutical Company LJPC fell 53.6% to close at $2.59 after the company reported that President and CEO George Tidmarsh has left the company. La Jolla Pharmaceutical disclosed that it will reassess continued development of LJPC-401 based on recent clinical results.
• Adamis Pharmaceuticals Corp ADMP shares dropped 51% to close at $0.6179 after the company reported it received a complete response letter from the FDA for its ZIMHI. The FDA stated it cannot approve the ZIMHI in its present form and provided suggested needed for resubmission.
• Kazia Therapeutics Limited KZIA fell 24.2% to close at $5.61 after reporting interim data from ongoing Phase 2 study of GDC-0084 in glioblastoma.
• BlueLinx Holdings Inc. BXC fell 23.2% to close at $9.55.
• Surface Oncology, Inc. SURF shares declined 21% to close at $1.8400 after the company reported a $25 million debt financing from K2 HealthVentures.
• Kirkland Lake Gold Ltd KL shares dipped 17.2% to close at $39.44 after the company, along with Detour Gold, announced Kirkland Lake Gold will acquire all of the issued and outstanding securities of Detour Gold.
• Akerna Corp. KERN dipped 15.3% to close at $6.13.
• AMERI Holdings, Inc. AMRH shares dropped 14.6% to close at $2.3261.
• Vislink Technologies Inc VISL tumbled 14.3% to close at $0.2530. Vislink Technologies priced its common stock and warrant offering for $4 million.
• Wah Fu Education Group Limited WAFU fell 13.7% to close at $2.34.
• Protagonist Therapeutics, Inc. PTGX dropped 11.9% to close at $8.34.
• Scholar Rock Holding Corporation SRRK fell 11.3% to close at $9.38.
• Aurora Mobile Limited JG dipped 10.5% to close at $3.00.
• CANAAN INC. CAN fell 7.7% to close at $8.29. The stock has been volatile since Thursday's IPO, in which it opened at $12.60, above the IPO price of $9.